INNOCAN PHARMA CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.1800 CAD | +2.86% |
|
-7.69% | -14.29% |
| Dec. 31 | Innocan Pharma Closes Private Placement for $635,444 | MT |
| Dec. 30 | InnoCan Pharma Corporation announced that it has received CAD 0.635445 million in funding | CI |
EPS & Dividend: InnoCan Pharma Corporation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Dividend per Share 2 | - | - | - | - | - |
| Rate of return | - | - | - | - | - |
| EPS 2 | -0.0276 | -0.0614 | -0.0447 | -0.0151 | -0.0183 |
| Distribution rate | - | - | - | - | - |
| Reference price 2 | 0.1234 | 0.2629 | 0.6322 | 0.1589 | 0.2347 |
| Nbr of stocks (in thousands) | 143,866 | 186,523 | 248,490 | 249,728 | 268,002 |
| Announcement Date | 4/8/20 | 3/31/21 | 3/31/22 | 3/30/23 | 4/1/24 |
1USD in Million2USD
Estimates
Upcoming events: InnoCan Pharma Corporation
| 2025-03-26 | Q4 2024 Earnings Release (Projected) |
| 2025-06-01 | Q1 2025 Earnings Release (Projected) |
| 2025-08-31 | Q2 2025 Earnings Release (Projected) |
| Yield | Yield | P/E ratio | Price to Book | EV / Sales | ||
|---|---|---|---|---|---|---|
| +0.72% | +0.83% | 57.77x | 38.65 | 14.92x | ||
| +3.24% | +3.41% | 21.23x | 4.966 | 4.11x | ||
| +1.90% | +2.42% | 25.72x | 18.12 | 9.14x | ||
| +3.63% | +3.80% | 38.17x | 38.53 | 6.45x | ||
| +3.11% | +3.27% | 13.9x | 5.244 | 4.23x | ||
| +3.71% | +3.81% | 15.8x | 5.922 | 3.77x | ||
| +2.33% | +2.47% | 24.7x | 5.003 | 4.3x | ||
| +3.88% | +4.02% | 17.88x | 4.378 | 4.15x | ||
| +6.34% | +6.46% | 14.97x | 1.675 | 3.29x | ||
| Average | +3.21% | +3.39% | 25.57x | 13.61 | 6.04x | |
| Weighted average by Cap. | +2.67% | +2.86% | 31.11x | 18.51 | 7.61x |
